
Alopexx
ALPXFiledAlopexx, Inc. · NYSE American (proposed) · Clinical-stage biotechnology · Research source · S-1/A #19 · Research as of 2026/09/17 · Latest filing · S-1/A · 2026-11-06 SEC ↗ · SEC checked 2026-11-21
Saved research available · S-1/A
As of the linked September 17, 2026 S-1/A, Alopexx has not completed its proposed IPO and is developing clinical-stage PNAG-targeted immune therapeutics.
Updates and this research have separate source dates; newer facts do not silently replace earlier conclusions.
High-risk biotech: low cash and further funding needs remain central
The September 17 amendment retains 3M shares at $10–$12 and about $30.1M estimated net proceeds at $11. Its June 30 accounts show a $1.011M first-half loss, $97,586 cash and a $17.724M accumulated deficit.
Full source-backed summary
The September 17 amendment retains 3M shares at $10–$12 and about $30.1M estimated net proceeds at $11. Its June 30 accounts show a $1.011M first-half loss, $97,586 cash and a $17.724M accumulated deficit. A $1.5M stock-purchase commitment was terminated in August; a separate $350K related-party loan followed. Vlock's stated 56.1% post-offer beneficial ownership includes options, rather than a clean economic ownership split.
- Business and development direction
A clinical-stage developer of PNAG-targeted vaccines and monoclonal antibodies against bacterial, fungal and parasitic infections.
Current business Clinical-stage biotechnology100%
Future development AV0328 proof of concept
F598 scale-up and trials
Working capital
Key risks
Risk 1
No product is approved. Clinical trials and regulatory approval remain uncertain; planned IPO funding is not completed financing.
Risk 2
June 30 cash was $97,586 against a $17.724M accumulated deficit. The source retains substantial doubt about going concern; first-half losses cannot be treated as a full-year result.
Risk 3
The August 7 termination ended BCI's $1.5M stock-purchase commitment with no further payment due; licensing arrangements were unaffected. A separate August 17 related-party $350K loan carries 12% interest and earlier repayment upon specified financing, or August 17, 2028. Neither event changes June 30 cash.
Capital raised and seller liquidity
- Issuer proceeds
- $30.1M
No estimate is substituted for missing offer terms.
| # | Institution | Underwriting allocation | Ratio | Shares |
|---|---|---|---|---|
| 1 | ThinkEquity LLC |
IPO CAPITAL QUALITY
| Calculation | Reported value |
|---|---|
| Issuer capital | $30.1M |
Basis and evidence
No estimate is substituted for missing offer terms. Company: estimated net proceeds
Capital quality is not yet quantifiable from the filed terms. IPO177 will calculate it when primary/secondary shares, fees and net proceeds are all disclosed.
Offering structure
| Measure | Reported value | Unit |
|---|---|---|
| Shares offered | 3,000,000 | Shares |
Source and calculation
Prospectus offering table; stated base scenario and source conditions Figures retain their stated source scenario and conditions.
Prospectus offering table; stated base scenario and source conditions
SEC table 8 row 2; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗Dilution and valuation
Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.
| Calculation | Shares | Value | Reference |
|---|---|---|---|
| Post-offer shares — as disclosed | 8,350,506 | — | |
| Post-offer shares — full option | 8,800,506 | — | |
| Capitalization shares — pro forma | 5,350,506 | — | |
| Capitalization shares — pro forma as adjusted | 8,350,506 | — | |
| Shares offered | 3,000,000 | — |
Basis and evidence ↗
Prospectus share summary; Common stock to be outstanding immediately after this Offering(1); 8,350,506 shares (8,800,506 shares if the underwriters exercise their over-allotment option in full).; selected security: shares; selected scenario: as disclosed; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Common stock to be outstanding immediately after this Offering(1); 8,350,506 shares (8,800,506 shares if the underwriters exercise their over-allotment option in full).; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: pro forma; Common Stock, $.0001 par value – 100,000,000 shares authorized, 5,155,081 shares issued and outstanding, 5,350,506 shares issued and outstanding pro forma, 8,350,506 shares issued and outstanding pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: pro forma as adjusted; Common Stock, $.0001 par value – 100,000,000 shares authorized, 5,155,081 shares issued and outstanding, 5,350,506 shares issued and outstanding pro forma, 8,350,506 shares issued and outstanding pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Prospectus offering table; stated base scenario and source conditions
Prospectus offering table; stated base scenario and source conditions Figures retain their stated source scenario and conditions.
Share-count comparison
Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.
Source ↗IPO valuation scenario simulator
Source inputs required
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Source ↗Source and calculation ↗
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.
Each reported full-option, actual, diluted or class-specific case remains independent; no class sum or cross-date substitution is inferred.
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.
These saved displays are not verified valuation inputs. Their stage, precision and assumptions have not been established by the current source.
Pre-offer shares · 5.350506M · $58.86M* · $11; includes note conversion
Base post-offer · 8.350506M · $91.86M* · +56.07% shares
Full option · 8.800506M · $96.81M* · +64.48% shares
June 30 actual shares · 5.155081M · 195,425 conversion shares* · *At IPO closing; no options
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Ownership across stages | Comparable ownership figures across stages are unavailable in this report. See Control for holdings on their disclosed basis. Open filing ↗ |
September 17 base-offer beneficial ownership, including options exercisable within 60 days and assumed note conversion
- Voting
- Majority expected*
- Economic
- 56.1% beneficial*
- As of
- 2026/09/17
Relationship filters
Select for details · Vlock; option-inclusive basis
Holdings and voting rights
Holder groups may overlap; these rows are not an additive ownership partition.
| Holder / measure | Shares | Ownership | Voting rights | Reference |
|---|---|---|---|---|
| Daniel VlockOwnership as disclosed | — | 56.1%Beneficial | — | Source statement; as stated; source predicate: will hold; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of our outstanding common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60; not an additive ownership partition |
| our executive officers, directors and 5% stockholdersOwnership as disclosed | — | approximately 97.84%Beneficial | — | Source statement; approximately ; source predicate: beneficially owned; primary source clause; full source conditions retained; source scope: of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately; not an additive ownership partition |
| our executive officers, directors and 5% stockholdersOwnership as disclosed | — | approximately 72.9%Beneficial | — | Source statement; approximately ; source predicate: will continue to beneficially own; primary source clause; full source conditions retained; source scope: of our outstanding voting stock; not an additive ownership partition |
| Daniel VlockVoting power | — | — | approximately 56.1%Voting power | Source statement; approximately ; source predicate: will beneficially own; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of the voting power of our common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable wi; not an additive ownership partition |
| Daniel VlockBeneficial shares | 4,546,958 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Daniel VlockBeneficial shares | 4,684,334 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Peter WerthBeneficial shares | 535,623 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Peter WerthBeneficial shares | 568,967 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Dr. Gerald PierBeneficial shares | 627,850 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Dr. Gerald PierBeneficial shares | 627,850 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Gail H. CassellBeneficial shares | 11,600 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Gail H. CassellBeneficial shares | 11,600 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Richard CohenBeneficial shares | 11,600 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Richard CohenBeneficial shares | 11,600 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Ann MacDougallBeneficial shares | 11,600 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Ann MacDougallBeneficial shares | 11,600 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Daniel VlockBeneficial ownership | — | 87.2%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Daniel VlockBeneficial ownership | — | 56.1%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| Peter WerthBeneficial ownership | — | 10.4%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Peter WerthBeneficial ownership | — | 6.8%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| Dr. Gerald PierBeneficial ownership | — | 11.1%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Dr. Gerald PierBeneficial ownership | — | 7.5%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| Gail H. CassellBeneficial ownership | — | 0.2%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Gail H. CassellBeneficial ownership | — | 0.1%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| Richard CohenBeneficial ownership | — | 0.2%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Richard CohenBeneficial ownership | — | 0.1%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| Ann MacDougallBeneficial ownership | — | 0.2%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Ann MacDougallBeneficial ownership | — | 0.1%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| Christine de los ReyesBeneficial shares | 191,400 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Christine de los ReyesBeneficial shares | 191,400 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| William W. ChinBeneficial shares | 281,213 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| William W. ChinBeneficial shares | 281,213 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Thomas T. ThomasBeneficial shares | 328,425 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| Thomas T. ThomasBeneficial shares | 328,425 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial shares | 5,382,796 | — | — | Shares Beneficially OwnedBefore Offering; Number of Shares |
| All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial shares | 5,520,172 | — | — | Shares Beneficially OwnedAfter Offering; Number of Shares |
| Christine de los ReyesBeneficial ownership | — | 3.6%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Christine de los ReyesBeneficial ownership | — | 2.3%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| William W. ChinBeneficial ownership | — | 5.2%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| William W. ChinBeneficial ownership | — | 3.4%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| Thomas T. ThomasBeneficial ownership | — | 6%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| Thomas T. ThomasBeneficial ownership | — | 3.9%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
| All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial ownership | — | 89%Beneficial | — | Shares Beneficially OwnedBefore Offering; Percentage |
| All Directors, Executive Officers and Director Nominees as a group (7 persons)Beneficial ownership | — | 66.1%Beneficial | — | Shares Beneficially OwnedAfter Offering; Percentage |
Source and calculation ↗
Source statement; as stated; source predicate: will hold; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of our outstanding common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60; not an additive ownership partition
Upon completion of this offering, Daniel Vlock, our President and Chief Executive Officer, will hold a majority of the voting power of our capital stock through his beneficial ownership of 56.1% of our outstanding common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option. As a result, we will be a “controlled company” under the listing requirements of the NYSE American, or the NYSE American Marketplace Rules. We do not intend to rely on any exemptions from the corporate governance requirements of the NYSE American Marketplace Rules. See the section titled “Management — Controlled Company Status.”
Source statement; approximately ; source predicate: beneficially owned; primary source clause; full source conditions retained; source scope: of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately; not an additive ownership partition
Prior to this offering, our executive officers, directors and 5% stockholders beneficially owned approximately 97.84% of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately 72.9% of our outstanding voting stock. Accordingly, even after this offering, these stockholders will have the ability to influence us through this ownership position and significantly affect the outcome of all matters requiring stockholder approval. For example, these stockholders may be able to significantly affect the outcome of elections of directors, amendments of our organizational documents or approval of any merger, sale of assets or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. In addition, these stockholders acquired their shares of common stock for substantially less than the price of the shares of common stock being acquired in this offering, and these stockholders may have interests, with respect to their common stock, that are different from those of investors in this offering and the concentration of voting power among these stockholders may have an adverse effect on the price of our common stock.
Source statement; approximately ; source predicate: will continue to beneficially own; primary source clause; full source conditions retained; source scope: of our outstanding voting stock; not an additive ownership partition
Prior to this offering, our executive officers, directors and 5% stockholders beneficially owned approximately 97.84% of our voting stock as of June 30, 2026 and, upon the closing of this offering, that same group will continue to beneficially own approximately 72.9% of our outstanding voting stock. Accordingly, even after this offering, these stockholders will have the ability to influence us through this ownership position and significantly affect the outcome of all matters requiring stockholder approval. For example, these stockholders may be able to significantly affect the outcome of elections of directors, amendments of our organizational documents or approval of any merger, sale of assets or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. In addition, these stockholders acquired their shares of common stock for substantially less than the price of the shares of common stock being acquired in this offering, and these stockholders may have interests, with respect to their common stock, that are different from those of investors in this offering and the concentration of voting power among these stockholders may have an adverse effect on the price of our common stock.
Source statement; approximately ; source predicate: will beneficially own; primary source clause; source condition: assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option; source scope: of the voting power of our common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable wi; not an additive ownership partition
Following this offering, Daniel Vlock, our President and Chief Executive Officer, will beneficially own approximately 56.1% of the voting power of our common stock, assuming the conversion of the outstanding convertible notes into 195,425 shares of common stock and including shares underlying vested options exercisable within 60 days, and assuming no exercise of the underwriters’ over-allotment option. As a result, we will be a “controlled company” within the meaning of the NYSE American corporate governance standards. Under these corporate governance standards, a company of which more than 50% of the voting power in the election of directors is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements. For example, controlled companies are not required to have:
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Daniel Vlock(2)
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Daniel Vlock(2)
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Peter Werth
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Peter Werth
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Dr. Gerald Pier
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Dr. Gerald Pier
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Gail H. Cassell
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Gail H. Cassell
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Richard Cohen
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Richard Cohen
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Ann MacDougall
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Ann MacDougall
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Daniel Vlock(2)
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Daniel Vlock(2)
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Peter Werth
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Peter Werth
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Dr. Gerald Pier
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Dr. Gerald Pier
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Gail H. Cassell
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Gail H. Cassell
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Richard Cohen
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Richard Cohen
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Ann MacDougall
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Ann MacDougall
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Christine de los Reyes
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Christine de los Reyes
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: William W. Chin
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: William W. Chin
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: Thomas T. Thomas
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: Thomas T. Thomas
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Number of Shares; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Number of Shares; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Number of Shares; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Christine de los Reyes
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Christine de los Reyes
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: William W. Chin
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: William W. Chin
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: Thomas T. Thomas
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: Thomas T. Thomas
Exact source ownership column: Shares Beneficially OwnedBefore Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedBefore Offering; Percentage; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)
Exact source ownership column: Shares Beneficially OwnedAfter Offering; Percentage; holders may overlap; not an additive partition
Raw source column: Shares Beneficially OwnedAfter Offering; Percentage; source holder: All Directors, Executive Officers and Director Nominees as a group (7 persons)
Saved control snapshot
The dated saved report retains its own figures and assumptions. These strings are not new calculation inputs.
| Holder / measure | Shares | Ownership | Voting rights | Reference |
|---|---|---|---|---|
| Vlock; option-inclusive basisControlling party | — | 56.1% beneficial | Majority expected* | 2026/09/17September 17 base-offer beneficial ownership, including options exercisable within 60 days and assumed note conversionS-1/A #19 ↗ |
| Other holdersMajor ownership group | — | Not a disjoint remainder | — | 2026/09/17September 17 base-offer beneficial ownership, including options exercisable within 60 days and assumed note conversionS-1/A #19 ↗ |
| IPO shares / conditional base sharesPublic / new investors | — | 35.93% base shares | — | 2026/09/17September 17 base-offer beneficial ownership, including options exercisable within 60 days and assumed note conversionS-1/A #19 ↗ |
Economic ownership
A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.
Share supply
Source lock-up conditions
Literal month restriction; after date of this prospectus; full conditions and exceptions remain in the source paragraph
| Measure | Reported value |
|---|---|
| Our executive officers and directorsAfter date of this prospectus · Source conditions apply | 12 months |
| Our executive officers and directorsAfter date of this prospectus · Source conditions apply | 12 months |
| our stockholdersAfter date of this prospectus · Source conditions apply | 6 months |
| our stockholdersAfter date of this prospectus · Source conditions apply | 6 months |
Source and calculation
Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
SEC lock-up paragraph; source 214766:215682; SHA256 66834fcf3d774b620abe544f6b3f3ff7140ab2dfc3ccbdc777b210153f0c5981 ↗Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
SEC table 8 row 7; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
SEC lock-up paragraph; source 214766:215682; SHA256 66834fcf3d774b620abe544f6b3f3ff7140ab2dfc3ccbdc777b210153f0c5981 ↗Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 12 months from the date of this prospectus, and all of our stockholders have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for a period of 6 months from the date of this prospectus. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
SEC table 8 row 7; source 199480:219857; SHA256 397ebe6f327438080add9f1f3b80d41d575c0b81807d291d5b71848035078430 ↗Source lock-up conditions
| Measure | Reported value |
|---|---|
| We, along with our directors, executive officers and all of our other stockholders and option holders,After date of this prospectus · Source conditions apply | 365 days |
| the warrantsAfter effective date of the registration statement · Source conditions apply | 180 days |
Source and calculation
We, along with our directors, executive officers and all of our other stockholders and option holders, have agreed with the underwriters that for a period of 365 days with respect to us, our directors and executive officers and 180 days with respect to all of our other stockholders and option holders, after the date of this prospectus, subject to specified exceptions as detailed further in the section entitled “Underwriting,” we or they will not, except with the prior written consent of ThinkEquity offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to sale of, or otherwise dispose of or transfer any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock, request or demand that we file a registration statement related to our common stock or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common stock. All of our stockholders are subject to a market stand-off agreement with us which imposes similar restrictions.
SEC lock-up paragraph; source 3001250:3002859; SHA256 7be8ad8253006ced8e7bf463ae7934930a9af07b5daffe51a27c5d7820886c96 ↗The Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for registration rights upon request, in certain cases. The one-time demand registration right provided will not be greater than five years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(C). The unlimited piggyback registration right provided will not be greater than seven years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.
SEC lock-up paragraph; source 3085884:3088019; SHA256 fe72cc4c6049f427c0bcb8b546d3f8a17e44c85d13665285312a8ee437e54eb2 ↗Conditional lock-up timeline
Conditional lock-up timeline
Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.
Milestones and unconfirmed releases
| Holder / event | Term / date | Conditions |
|---|---|---|
| Other holders | +180 days from prospectus Not separately quantified · other existing shares and options | Other holders · Other stockholders and option holders · Not yet published — awaiting the effective or final prospectus. · 180 days from final prospectus, subject to exceptions and prior written ThinkEquity consent; resale law also applies · Cumulative: Not separately quantified (No disjoint pool disclosed) · No trading-volume basis is available; calculate after 20 trading sessions. |
Basis and evidence
Other holders · Other stockholders and option holders · Not yet published — awaiting the effective or final prospectus. · 180 days from final prospectus, subject to exceptions and prior written ThinkEquity consent; resale law also applies · Cumulative: Not separately quantified (No disjoint pool disclosed) · No trading-volume basis is available; calculate after 20 trading sessions.
Lock-up / shares eligible for future sale ↗Financial quality
Bars compare absolute amounts within each measure. Each measure has its own scale.
Net income / (loss)
$ · Annual values as reportedOperating cash flow
$ · Annual values as reported| Calculation | FY2024 | FY2025 |
|---|---|---|
| Net income / (loss) | ($3,060,624) | ($2,608,394) |
| Operating cash flow | ($481,234) | ($1,140,128) |
| Calculation | Reported value |
|---|---|
| Current assets2026-06-30 · Unaudited | $981,003 |
| Current assets2025-12-31 | $911,886 |
| Total assets2026-06-30 · Unaudited | $981,003 |
| Total assets2025-12-31 | $911,886 |
| Current liabilities2026-06-30 · Unaudited | $5,036,726 |
| Current liabilities2025-12-31 | $6,203,025 |
| Total liabilities2026-06-30 · Unaudited | $7,403,393 |
| Total liabilities2025-12-31 | $7,003,025 |
| Total equity / (deficit)2026-06-30 · Unaudited | ($6,422,390) |
| Total equity / (deficit)2025-12-31 | ($6,091,139) |
| General and administrative expenses3M ended 2026-06-30 · Unaudited | $256,981 |
| General and administrative expenses3M ended 2025-06-30 · Unaudited | $618,514 |
| General and administrative expenses6M ended 2026-06-30 · Unaudited | $604,164 |
| General and administrative expenses6M ended 2025-06-30 · Unaudited | $1,277,540 |
| Net income / (loss)3M ended 2026-06-30 · Unaudited | ($541,829) |
| Net income / (loss)3M ended 2025-06-30 · Unaudited | ($746,042) |
| Net income / (loss)6M ended 2026-06-30 · Unaudited | ($1,010,625) |
| Net income / (loss)6M ended 2025-06-30 · Unaudited | ($1,529,267) |
| Operating cash flow6M ended 2026-06-30 · Unaudited | ($530,883) |
| Operating cash flow6M ended 2025-06-30 · Unaudited | ($626,962) |
| Current assets2024-12-31 | $1,152,014 |
| Total assets2024-12-31 | $1,152,014 |
| Current liabilities2024-12-31 | $6,078,307 |
| Total liabilities2024-12-31 | $6,278,307 |
| General and administrative expensesFY2025 | $2,118,730 |
| General and administrative expensesFY2024 | $2,590,815 |
| Product revenue | $0 |
| H1 2026 net loss | $(1.011M) |
| Cash at June 30 | $97,586 |
| Accumulated deficit | $(17.724M) |
| Going concern | Substantial doubt |
Basis and evidence
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Financial review | Reported financial figures are shown above. A cash-runway estimate needs compatible cash-flow and funding assumptions. Open filing ↗ |
S-1/A #18 → S-1/A #19
The latest material signals and their investor impact are shown below.
Why it mattersChanges dilution, public float and potential supply.
Evidence · S-1/A #19 · 2026/09/17Why it mattersChanges valuation, proceeds and first-day return assumptions.
Evidence · S-1/A #19 · 2026/09/17S-1
• Initial IPO registration began
• Clinical-stage profile disclosed
S-1/A #18
• Prior source retained 3M shares at $10–$12
• Interim accounts then covered March 31
S-1/A #19
• June 30 interim accounts and 8,350,506 conditional base shares
• Discloses August BCI purchase termination and $350K related-party loan; no final price or listing date
No product is approved. Clinical trials and regulatory approval remain uncertain; planned IPO funding is not completed financing.
- Potential impact
- Very high
- Evidence
- S-1/A #19 · 2026/09/17 ↗
June 30 cash was $97,586 against a $17.724M accumulated deficit. The source retains substantial doubt about going concern; first-half losses cannot be treated as a full-year result.
- Potential impact
- Very high
- Evidence
- S-1/A #19 · 2026/09/17 ↗
The August 7 termination ended BCI's $1.5M stock-purchase commitment with no further payment due; licensing arrangements were unaffected. A separate August 17 related-party $350K loan carries 12% interest and earlier repayment upon specified financing, or August 17, 2028. Neither event changes June 30 cash.
- Potential impact
- High
- Evidence
- S-1/A #19 · 2026/09/17 ↗
Vlock is expected to retain majority voting power. The stated 56.1% beneficial stake includes options; outstanding options and reserved plan shares can dilute investors beyond the conditional base offering.
- Potential impact
- High
- Evidence
- S-1/A #19 · 2026/09/17 ↗
Sources and calculation notes
September 17 source: June accounts, conditional share conversion and August financing events; final IPO terms remain pending